Search research articles
Contact Us
Filters
Showing results (51-60 of 193) with videos related to
Page
of 20
Sort By:
Journal of Clinical Psychopharmacology
|
August 1, 1991
Treatment of social phobia with bupropion
N P Emmanuel, R B Lydiard, J C Ballenger
Psychopharmacology Bulletin
|
January 1, 1996
Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial
H Katschnig, M Amering, J M Stolk, et al.
The Journal of Clinical Psychiatry
|
October 1, 1993
Medication discontinuation in panic disorder
J C Ballenger, J Pecknold, K Rickels, et al.
Hospital & Community Psychiatry
|
November 1, 1988
Recent advances in the psychopharmacological treatment of anxiety disorders
R B Lydiard, P P Roy-Byrne, J C Ballenger
The American Journal of Psychiatry
|
May 1, 1989
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal
R Malcolm, J C Ballenger, E T Sturgis, et al.
The American Journal on Addictions
|
March 28, 2001
Update on anticonvulsants for the treatment of alcohol withdrawal
R Malcolm, H Myrick, K T Brady, et al.
The American Journal of Psychiatry
|
October 1, 1988
Possible relationship of bowel obsessions to panic disorder with agoraphobia
R B Lydiard, M T Laraia, M Fossey, et al.
Biological Psychiatry
|
March 1, 1988
Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis
M E Brown, R F Anton, R Malcolm, et al.
The Journal of Clinical Psychiatry
|
December 1, 1991
Cocaine-induced psychosis
K T Brady, R B Lydiard, R Malcolm, et al.
The American Journal of Psychiatry
|
March 1, 1980
Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine
P W Gold, I Extein, J C Ballenger, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 193) with videos related to
Sort By:
Page
of 20
Journal of Clinical Psychopharmacology
|
August 1, 1991
Treatment of social phobia with bupropion
N P Emmanuel, R B Lydiard, J C Ballenger
Psychopharmacology Bulletin
|
January 1, 1996
Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial
H Katschnig, M Amering, J M Stolk, et al.
The Journal of Clinical Psychiatry
|
October 1, 1993
Medication discontinuation in panic disorder
J C Ballenger, J Pecknold, K Rickels, et al.
Hospital & Community Psychiatry
|
November 1, 1988
Recent advances in the psychopharmacological treatment of anxiety disorders
R B Lydiard, P P Roy-Byrne, J C Ballenger
The American Journal of Psychiatry
|
May 1, 1989
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal
R Malcolm, J C Ballenger, E T Sturgis, et al.
The American Journal on Addictions
|
March 28, 2001
Update on anticonvulsants for the treatment of alcohol withdrawal
R Malcolm, H Myrick, K T Brady, et al.
The American Journal of Psychiatry
|
October 1, 1988
Possible relationship of bowel obsessions to panic disorder with agoraphobia
R B Lydiard, M T Laraia, M Fossey, et al.
Biological Psychiatry
|
March 1, 1988
Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis
M E Brown, R F Anton, R Malcolm, et al.
The Journal of Clinical Psychiatry
|
December 1, 1991
Cocaine-induced psychosis
K T Brady, R B Lydiard, R Malcolm, et al.
The American Journal of Psychiatry
|
March 1, 1980
Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine
P W Gold, I Extein, J C Ballenger, et al.
Page
of 20